Adalimumab BS Subcutaneous Injection 20mg Syringe 0.2mL "MA" (アダリムマブBS皮下注20mgシリンジ0.2mL「MA」)

Quốc gia: Nhật Bản

Ngôn ngữ: Tiếng Anh

Nguồn: すりの適正使用協議会 RAD-AR Council, Japan

Buy It Now

Download Tờ rơi thông tin (PIL)
01-11-2021

Thành phần hoạt chất:

Adalimumab(genetical recombination)[adalimumab biosimilar 3]

Sẵn có từ:

AYUMI Pharmaceutical Co., Ltd.

INN (Tên quốc tế):

Adalimumab(genetical recombination)[adalimumab biosimilar 3]

Dạng dược phẩm:

colorless and almost limpid or slightly opalescent peculiar to protein injectable solution in a prefilled syringe

Tờ rơi thông tin

                                Drug Information Sheet("Kusuri-no-Shiori")
Self-injection
Published: 11/2021
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
ADALIMUMAB BS SUBCUTANEOUS INJECTION
20MG SYRINGE 0.2ML "MA"
ACTIVE INGREDIENT:
Adalimumab(genetical recombination)[adalimumab
biosimilar 3]
DOSAGE FORM:
colorless and almost limpid or slightly opalescent peculiar to
protein injectable solution in a prefilled syringe
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine suppresses the function of TNF (tumor necrosis
factor)-α, which is one of the
possible primary causative substances in juvenile idiopathic
arthritis. TNF is one of the
cytokines existing inside of the body even in a healthy state, and
involved in activities of
immunity and development of inflammation or pain.
It is usually used to treat active polyarticular-juvenile idiopathic
arthritis with inadequate
response to conventional therapies.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have or are suspected of having infections such as sepsis.
If you have or have a history of tuberculosis or blood disease.
If you have or have a past medical or family history of demyelinating
diseases such as
multiple sclerosis.
If you are a hepatitis B virus carrier or have a history of hepatitis
B virus infection.
If you have just received live vaccine.
If you have congestive heart failure.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal 
                                
                                Đọc toàn bộ tài liệu
                                
                            

Tìm kiếm thông báo liên quan đến sản phẩm này